| Lastest Insider Transactions Of ARROWHEAD PHARMACEUTICALS, INC. ( ARWR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2021-01-14 | Sell | 10,000 | 81.29 | 812,942 | 2021-01-15 17:49:36 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2021-01-11 | Sell | 13,038 | 81.02 | 1,056,310 | 2021-01-12 18:06:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hassard James | Chief Commercial Officer | 2021-01-07 | Sell | 15,625 | 75.00 | 1,171,875 | 2021-01-08 18:05:07 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | 2021-01-06 | Sell | 25,000 | 72.41 | 1,810,346 | 2021-01-07 18:11:06 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2021-01-06 | Sell | 30,625 | 72.44 | 2,218,477 | 2021-01-07 18:08:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2021-01-05 | Sell | 38,750 | 72.51 | 2,809,579 | 2021-01-07 18:02:41 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2021-01-01 | Sell | 4,000 | 76.09 | 304,360 | 2021-01-05 18:14:01 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2021-01-01 | Sell | 4,000 | 76.08 | 304,320 | 2021-01-05 18:11:24 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2021-01-01 | Sell | 3,750 | 76.08 | 285,300 | 2021-01-05 18:01:45 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-12-18 | Option Exercise | 40,510 | 5.73 | 232,006 | 2020-12-22 17:55:40 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2020-12-07 | Sell | 9,575 | 79.32 | 759,443 | 2020-12-18 18:26:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2020-12-10 | Sell | 3,000 | 71.26 | 213,780 | 2020-12-11 18:16:59 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-12-08 | Sell | 55,000 | 68.73 | 3,780,347 | 2020-12-10 19:07:52 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-12-08 | Option Exercise | 55,000 | 2.01 | 110,550 | 2020-12-10 19:07:52 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Bradshaw Curt | Chief Scientific Officer | 2020-11-19 | Sell | 31,250 | 69.06 | 2,158,125 | 2020-11-23 17:58:54 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | 2020-11-19 | Sell | 19,500 | 69.39 | 1,353,105 | 2020-11-20 18:03:03 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-11-09 | Sell | 43,505 | 69.37 | 3,018,071 | 2020-11-12 17:49:23 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-11-09 | Option Exercise | 43,505 | 14.54 | 632,563 | 2020-11-12 17:49:23 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Directior | 2020-10-08 | Buy | 1,000 | 50.47 | 50,465 | 2020-10-26 18:02:00 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-10-23 | Sell | 100,000 | 58.21 | 5,821,032 | 2020-10-23 19:35:13 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-10-20 | Sell | 29,166 | 54.04 | 1,576,131 | 2020-10-22 18:02:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-10-20 | Option Exercise | 29,166 | 6.15 | 179,371 | 2020-10-22 18:02:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2020-10-09 | Sell | 10,000 | 48.00 | 480,000 | 2020-10-13 18:01:48 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-08-13 | Sell | 50,000 | 41.35 | 2,067,500 | 2020-08-14 18:08:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-08-13 | Option Exercise | 50,000 | 9.90 | 495,000 | 2020-08-14 18:08:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2020-06-25 | Sell | 100,000 | 38.81 | 3,881,017 | 2020-06-26 18:02:53 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Directior | 2020-01-13 | Buy | 4,000 | 33.56 | 134,240 | 2020-06-24 18:10:45 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-14 | Option Exercise | 77,000 | 3.70 | 285,200 | 2020-05-18 18:27:18 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-12 | Sell | 36,000 | 35.83 | 1,289,891 | 2020-05-13 18:48:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-12 | Sell | 36,000 | 35.83 | 1,289,891 | 2020-05-13 18:48:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-12 | Sell | 36,000 | 35.83 | 1,289,891 | 2020-05-13 18:48:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-12 | Sell | 36,000 | 35.83 | 1,289,891 | 2020-05-13 18:48:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2020-05-12 | Sell | 36,000 | 35.83 | 1,289,891 | 2020-05-13 18:48:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2020-05-11 | Sell | 26,000 | 36.54 | 950,040 | 2020-05-13 18:45:26 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2020-05-11 | Sell | 26,000 | 36.54 | 950,040 | 2020-05-13 18:45:26 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2020-05-11 | Sell | 26,000 | 36.54 | 950,040 | 2020-05-13 18:45:26 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-01-21 | Sell | 40,313 | 49.44 | 1,992,925 | 2020-01-23 18:15:02 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2020-01-21 | Option Exercise | 33,351 | 5.19 | 173,092 | 2020-01-23 18:15:02 |
